STOCKWATCH
·
Other Pharmaceuticals
Quarterly ResultMay 6, 2026, 04:28 PM

Herbalife Q1 Net Sales $1.32B, Net Income $61.9M, EPS $0.57

AI Summary

Herbalife Ltd. reported strong financial results for the first quarter ended March 31, 2026, with net sales increasing to $1.32 billion and net income attributable to Herbalife reaching $61.9 million. Diluted earnings per share improved to $0.57. The company also saw a significant increase in net cash provided by operating activities to $113.8 million. Recent strategic activities include the acquisitions of Pruvit and Pro2col LLC, the business acquisition of Link BioSciences Inc., and a sponsorship and stock option agreement with Cristiano Ronaldo for HBL Pro2col Software, LLC.

Key Highlights

  • Net sales for Q1 2026 increased to $1,317.2 million from $1,221.7 million in Q1 2025.
  • Net income attributable to Herbalife for Q1 2026 rose to $61.9 million from $50.4 million in Q1 2025.
  • Diluted EPS for Q1 2026 was $0.57, up from $0.49 in Q1 2025.
  • Net cash provided by operating activities for Q1 2026 was $113.8 million, a significant increase from $0.2 million in Q1 2025.
  • Cash and cash equivalents increased to $451.2 million as of March 31, 2026, from $353.1 million at December 31, 2025.
  • Herbalife acquired Pruvit and Pro2col LLC assets for $19 million in April 2025.
  • Herbalife acquired Link BioSciences Inc. for $6.5 million in April 2025.
  • Cristiano Ronaldo's entity acquired a 10% equity interest in HBL Pro2col Software for $7.5 million.
HLF
Other Pharmaceuticals
HERBALIFE LTD.

Price Impact